UAB "Apeironpharma" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 537,218 |
| 134,305 |
| 78,849 |
| 67,022 |
| 16,756 |
| 36.50 |
| 12.48 |
| 214,399 |
| 366,388 |
| 444,776 |
| 151,159 |
| 2024 |
|---|
| 501,278 |
| 125,320 |
| 74,743 |
| 63,532 |
| 15,883 |
| 37.44 |
| 12.67 |
| 277,931 |
| 305,251 |
| 533,777 |
| 84,694 |
| 2025 |
|---|
| 543,051 |
| 135,763 |
| 84,023 |
| 70,579 |
| 17,645 |
| 37.12 |
| 13.00 |
| 348,510 |
| 205,755 |
| 506,166 |
| 61,543 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 543,051 |
| 135,763 |
| 84,023 |
| 70,579 |
| 17,645 |
| 37.12 |
| 13.00 |
| 348,510 |
| 205,755 |
| 506,166 |
| 61,543 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
543,051 €8 % *
Sales per employee (€)
135,763 €8 % *
Profit before tax (€)
84,023 €12 % *
Net Profit (€)
70,579 €11 % *
Profit per employee (€)
17,645 €11 % *
Total profitability (%)
37.12 %-0.85 % *
Net profitability (%)
13.00 %2.60 % *
Equity (€)
348,510 €25 % *
Amounts Payable And Liabilities (€)
205,755 €-33 % *
Non-current Assets (€)
506,166 €-5 % *
CurrentAssets (€)
61,543 €-27 % *
